Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Ezzeldin A Mostafa

Ezzeldin A Mostafa

Ain Shams University Hospital, Egypt

Title: Outcomes of right atrial electromaze ablation of supraventricular tachydysrhythmias in patients with non-neonatal Ebstein’s anomaly

Biography

Biography: Ezzeldin A Mostafa

Abstract

Background: Favorable outcomes in EA reparative procedures are predicated on tricuspid valve competence, right ventricular function and presence of arrhythmia. We report our experience with right atrial electromaze for supraventricular tachydysrhythmias in patients with non-neonatal Ebstein’s Anomaly (EA)

Objectives: Assessment of clinical outcomes of right atrial electromaze for supraventricular tachydysrhythmias in patients with non-neonatal Ebstein’s Anomaly (EA).

Method: Between January 2002 and December 2013, retrospective review of 37 patients had operations for refractory atrial dysrhythmias, 6-step right atrial electromaze with concomitant anatomy-specific repair, as a part of this three-step surgical protocol for Ebstein's anomaly was done. A 6th step had been added to previously described 5-step right atrial electromaze. Mechanisms of arrhythmia included atrial re-entry (n=16), atrial fibrillation (n=15), automatic atrial (n=3), accessory connections (n=6) and atrio-ventricular nodal reentry (n=2). Mean age at operation was 17.3 (9.1-56.2) years. Postoperatively all patients were followed up regularly for mean period 5.3 (1-12) years by clinical examination, electrocardiography and echocardiography.

Results: The in-hospital mortality was one patient (2.7%) with no late deaths. Doppler echocardiographic examination revealed significant improvement of valve regurgitation (p<0.0001). New York Heart Association (NYHA) functional class was class I in 77.8% of the survivors and II in 22.2%. Mild Tricuspid Regurgitation (TR) (grade-1) was found in 72.2% and required no treatment and moderate TR (grade-2) in 25% which necessitated continuous anti-failure medical treatment. The cardiothoracic ratio decreased significantly (p<0.05). No deleterious effects of the Bidirectional Cavopulmonary Anastomosis (BDCPA) have been reported. Sinus rhythm has remained stable over the follow-up period in 31 patients (86.1%).

Conclusion: Successful surgical therapy of arrhythmias can be performed safely at the time of repair of non-neonatal EA. Early consideration for single-stage therapy of arrhythmia and structural heart disease is indicated whether symptomatic or asymptomatic and cyanotic or acyanotic.